Feb 07–10, 2028 | Keystone Resort, Keystone, CO, United States
Scientific Organizers:
Georg E. Winter, Michael A. Erb, and Gwenn M Hansen
-
Scientific Organizers: Georg E. Winter, Michael A. Erb, and Gwenn M Hansen
Georg E. Winter, PhD
CeMM Research Center for Molecular Medicine
Michael A. Erb, PhD
The Scripps Research Institute
Gwenn M Hansen, PhD
Nurix Therapeutics
Important Deadlines
Meeting Summary
Induced proximity represents a transformative therapeutic paradigm that is revolutionizing drug discovery by offering new modes of controlling protein function beyond traditional inhibition. Targeted protein degradation (TPD), a modality focused on small molecules that induce proximity between disease-relevant target proteins and E3 ubiquitin ligases, best illustrates the power of this emerging field. However, TPD represents only a small fraction of the opportunity space offered by proximity-inducing medicines.
This Keystone Symposia conference on Induced Proximity: Emerging Technologies and Clinical Translation aims to showcase the latest technological innovations and therapeutic developments in the field. Central to the conference are the emerging frontiers of AI-enabled design, alongside the development of novel chemical tools and technological platforms for discovery and precise modulation. Specific sessions will highlight emerging clinical data and summarize the lessons learned from the translation of small molecule degraders into therapeutics.
By integrating experts in AI-driven design, chemical biology, and clinical development, the conference will create a unique platform where established pioneers and rising researchers from academia and industry define the next frontier of proximity-based biology. The conference will feature a shared keynote and plenary session with the joint Keystone Symposia conference on Ubiquitin: New Frontiers in Signaling and Cellular Regulation, while also reporting on the molecular mechanisms of chemical inducers of proximity (CIPs) that rewire protein function to induce novel biological outcomes beyond degradation.
The program’s core goal is to address the pressing challenges of transitioning the discovery of CIPs from serendipity to rational design and of translating these complex modalities into human therapeutics. The cross-disciplinary engagement at this conference will equip attending scientists with mechanistic and translational frameworks, inspiring the collaborations required to deliver the next wave of breakthroughs in non-traditional modalities for targeting disease.
Unique Career Development Opportunities
This meeting will feature a Career Roundtable where trainees and early-career investigators will have the opportunity to interact with field leaders from across academic and industry sectors for essential career development advice and networking opportunities. Find out more about Career Roundtables here: https://www.keystonesymposia.org/diversity/career-development-initiatives
SPECIAL RECOGNITION:
KEYSTONE SYMPOSIA THANKS OUR SPONSOR(S) FOR GENEROUSLY SUPPORTING THIS MEETING:
KEYSTONE SYMPOSIA THANKS OUR MEETING EXHIBITOR(S):
KEYSTONE SYMPOSIA THANKS THESE DONOR(S) FOR GENEROUSLY SUPPORTING THIS MEETING:
THESE COMPANIES HAVE GENEROUSLY AGREED TO COVER THE EXPENSES OF THEIR EMPLOYEES WHO ARE SPEAKING AT THIS MEETING:
GRANT RECOGNITION:
KEYSTONE SYMPOSIA THANKS OUR GIFT-IN-KIND MEDIA SPONSORS
Subscribe for Updates